Wockhardt recalls 1.62 lakh cartons of various drugs in US

17 Jul 2015 Evaluate

Wockhardt has recalled 1,62,142 cartons of various drugs, which are used to treat ailments like high blood pressure and ulcer, from the US market due to deviations in current good manufacturing practice norms laid down by the American health regulator. As per the US Food and Drug Administration (USFDA), Mumbai-based company has recalled the drugs for current good manufacturing practice (CGMP) deviations.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1436.00 -9.90 (-0.68%)
01-Jan-2026 09:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1711.50
Dr. Reddys Lab 1252.10
Cipla 1500.45
Zydus Lifesciences 907.95
Lupin 2092.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×